Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$18.78 USD
+0.46 (2.51%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $18.98 +0.20 (1.06%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.99 |
EPS Last Quarter | -0.90 |
Last EPS Surprise | 22.41% |
ABR | 1.13 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.80 |
Next Year | -5.30 |
EPS (TTM) | -5.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.99 | -1.06 | -3.80 | -5.30 |
# of Estimates | 6 | 6 | 5 | 6 |
Most Recent Consensus | NA | -0.82 | -3.33 | -2.54 |
High Estimate | -0.78 | -0.82 | -3.33 | -2.54 |
Low Estimate | -1.14 | -1.34 | -4.30 | -11.19 |
Year ago EPS | -2.27 | -1.81 | -10.31 | -3.80 |
Year over Year Growth Est. | 56.39% | 41.44% | 63.14% | -39.47% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.99 | -1.06 | -3.80 | -5.30 |
7 Days Ago | -0.99 | -1.06 | -3.80 | -5.30 |
30 Days Ago | -0.99 | -1.03 | -3.77 | -5.26 |
60 Days Ago | -0.98 | -1.02 | -3.77 | -4.08 |
90 Days Ago | -1.45 | -1.57 | -5.11 | -5.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.99 | -0.82 | -3.33 | -2.54 |
Zacks Consensus Estimate | -0.99 | -1.06 | -3.80 | -5.30 |
Earnings ESP | 0.00% | 22.28% | 12.42% | 52.09% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.90 | -0.83 | -1.81 | -2.27 | NA |
Estimate | -1.16 | -1.09 | -2.36 | -2.06 | NA |
Difference | 0.26 | 0.26 | 0.55 | -0.21 | 0.22 |
Surprise | 22.41% | 23.85% | 23.31% | -10.19% | 14.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more